3D bioprinting in cardiac tissue engineering

Theranostics. 2021 Jul 6;11(16):7948-7969. doi: 10.7150/thno.61621. eCollection 2021.

Abstract

Heart disease is the main cause of death worldwide. Because death of the myocardium is irreversible, it remains a significant clinical challenge to rescue myocardial deficiency. Cardiac tissue engineering (CTE) is a promising strategy for repairing heart defects and offers platforms for studying cardiac tissue. Numerous achievements have been made in CTE in the past decades based on various advanced engineering approaches. 3D bioprinting has attracted much attention due to its ability to integrate multiple cells within printed scaffolds with complex 3D structures, and many advancements in bioprinted CTE have been reported recently. Herein, we review the recent progress in 3D bioprinting for CTE. After a brief overview of CTE with conventional methods, the current 3D printing strategies are discussed. Bioink formulations based on various biomaterials are introduced, and strategies utilizing composite bioinks are further discussed. Moreover, several applications including heart patches, tissue-engineered cardiac muscle, and other bionic structures created via 3D bioprinting are summarized. Finally, we discuss several crucial challenges and present our perspective on 3D bioprinting techniques in the field of CTE.

Keywords: 3D bioprinting; bioinks; cardiac muscle; printed biomaterials; tissue engineering.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biocompatible Materials / chemistry
  • Bionics / methods
  • Bioprinting / methods*
  • Bioprinting / trends
  • Cardiac Surgical Procedures / methods
  • Heart / physiology
  • Heart Diseases / physiopathology
  • Heart Diseases / therapy
  • Humans
  • Myocardium / metabolism*
  • Printing, Three-Dimensional / trends
  • Tissue Engineering / methods*
  • Tissue Scaffolds / chemistry

Substances

  • Biocompatible Materials